Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV

Stopped early · Phase 4

Conditions studied: HIV

In brief

This study will evaluate how safe and tolerable a combination of taking three-drugs will be for the purpose of preventing HIV transmission after a high-risk sexual contact exposure in HIV uninfected adults.

Key facts

Study ID

NCT01602822

Run by

Kenneth H. Mayer, MD

People needed

11

Starts

2012-02-01

Expected to finish

2012-05-01

Last updated by the study team

2025-07-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age of 18 at time of first visit.
• HIV uninfected on the basis of a negative HIV Rapid Test
• Possible non-occupational exposure to HIV-1, recent enough to permit receiving the first dose of study medication within 72 hours from the end of the exposure.

You may not qualify if…

• Women who are actively trying to become pregnant.
• Pregnancy and/or Breastfeeding.
• Known self report of Chronic Hepatitis B infection or prior antiretroviral therapy for hepatitis B.
• Known intolerance or allergy to study drugs.

Where it is running

• Fenway Health — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.